Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma
Yongbin Zeng, Shanjian Chen, Ya Fu, et al.
Journal of Viral Hepatitis (2019) Vol. 27, Iss. 2, pp. 143-155
Closed Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Changes in Glutathione Content in Liver Diseases: An Update
Mariapia Vairetti, Laura Giuseppina Di Pasqua, Marta Cagna, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 364-364
Open Access | Times Cited: 197
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang, Qiuju Han, Huajun Zhao, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 435-450
Open Access | Times Cited: 168
Viral Infections, the Microbiome, and Probiotics
Ashton Harper, Vineetha Vijayakumar, Arthur C. Ouwehand, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 10
Open Access | Times Cited: 142
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Mohamed Kamel, Sami Aleya, Majed Alsubih, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 217-217
Open Access | Times Cited: 23
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 19
Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis
Ye Liu, Ziwei Chen, Chang Li, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 3
The lung tissue microbiota features of 20 deceased patients with COVID-19
Jun Fan, Xiang Li, Yong Gao, et al.
Journal of Infection (2020) Vol. 81, Iss. 3, pp. e64-e67
Open Access | Times Cited: 105
Profiling of tumour-associated microbiota in human hepatocellular carcinoma
Seiga Komiyama, Takahiro Yamada, Nobuyuki Takemura, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 73
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
Yue Shen, Shengdi Wu, Yao Chen, et al.
Gut Microbes (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 47
Exploring the potential impact of probiotic use on drug metabolism and efficacy
Carmen Purdel, Anca Ungurianu, Ines Adam-Dima, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114468-114468
Open Access | Times Cited: 32
Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
Fengna Yan, Qun Zhang, Ke Shi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 32
Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
Roman Maslennikov, Elena Poluektova, O. Yu. Zolnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16502-16502
Open Access | Times Cited: 26
Hepatitis B virus‐related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures
Yuanjie Liu, Elena S. Kim, Haitao Guo
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access | Times Cited: 9
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
Jia Wang, Cynthia Rajani, Hong‐Xi Xu, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 374-393
Open Access | Times Cited: 69
Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
Chathur Acharya, Jasmohan S. Bajaj
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 556-572
Open Access | Times Cited: 66
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Sally Temraz, Farah Nassar, Firas Kreidieh, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7800-7800
Open Access | Times Cited: 41
Role of Microbiota in Viral Infections and Pathological Progression
Taketoshi Mizutani, Aya Ishizaka, Michiko Koga, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 950-950
Open Access | Times Cited: 36
Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer
Shuyu Liu, Xilan Yang
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 21
Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions
Bing Yue, Yuxia Gao, Yi Hu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 7
Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease
Martin Marônek, René Link, Ľuboš Ambro, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 1013-1013
Open Access | Times Cited: 47
Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis
Shu Wu, Shanjian Chen, Jinpiao Lin, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 2, pp. 100676-100676
Open Access | Times Cited: 25
Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches
Priyankar Dey, Saumya Ray Chaudhuri
Biology (2022) Vol. 11, Iss. 5, pp. 757-757
Open Access | Times Cited: 25
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
Roman Maslennikov, Aliya Alieva, Elena Poluektova, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 27, pp. 4236-4251
Open Access | Times Cited: 15
Mendelian randomization supports causality between gut microbiota and chronic hepatitis B
Quan-Zheng Zhang, Jinhua Zhou, Xiaoxiao Zhang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15
Quercetin/Anti-PD-1 Antibody Combination Therapy Regulates the Gut Microbiota, Impacts Macrophage Immunity and Reshapes the Hepatocellular Carcinoma Tumor Microenvironment
Ruoxia Wu, Jiaqing Xiong, Ting Zhou, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 12, pp. 327-327
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top